A DR4 capturer with AKT siRNA for the synergetic enhancement of death receptor-mediated apoptosis.
A graphene-based nanocarrier modified with death receptor 4 (DR4) antibody and AKT siRNA has been developed, which can synergistically strengthen death receptor-mediated apoptosis and enhance the cancer therapeutic effect in vivo.